Peripherally Inserted Central Catheters Up VTE Risk

This article originally appeared here.
Share this content:
Peripherally Inserted Central Catheters Up VTE Risk
Peripherally Inserted Central Catheters Up VTE Risk

WEDNESDAY, Aug. 19, 2015 (HealthDay News) -- For hospitalized patients, peripherally inserted central catheter presence is associated with increased risk of upper- and lower-extremity deep vein thrombosis, according to a study published recently in The American Journal of Medicine.

M. Todd Greene, Ph.D., M.P.H., from The Michigan Hospital Safety Consortium in Ann Arbor, and colleagues conducted a retrospective study involving 76,242 hospitalized medical patients from 48 Michigan hospitals. Phone and record review was used to ascertain peripherally inserted central catheter presence, comorbidities, venous thrombosis risk factors, and thrombotic events within 90 days of hospital admission.

The researchers found that during hospitalization, 3,790 patients received a peripherally inserted central catheter. There were 876 thromboembolic events from hospital admission to 90 days. Independent correlations were seen for peripherally inserted central catheter use with all-cause venous thromboembolism (hazard ratio [HR], 3.16; 95 percent confidence interval [CI], 2.59 to 2.85), upper-extremity deep vein thrombosis (HR, 10.49; 95 percent CI, 7.79 to 14.11), and lower-extremity deep vein thrombosis (HR, 1.48; 95 percent CI, 1.02 to 2.15), after risk adjustment. There was no correlation for peripherally inserted central catheter use with pulmonary embolism (HR, 1.34; 95 percent CI, 0.86 to 2.06).

"Peripherally inserted central catheter use is associated with upper- and lower-extremity deep vein thrombosis," the authors write. "Weighing the thrombotic risks conferred by peripherally inserted central catheters against clinical benefits seems necessary."

Several authors disclosed financial ties to the health insurance industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »